BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17892361)

  • 1. CpG islands: their potential as biomarkers for cancer.
    Shi H; Wang MX; Caldwell CW
    Expert Rev Mol Diagn; 2007 Sep; 7(5):519-31. PubMed ID: 17892361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of DNA methylation markers for diagnosing cancer.
    Qureshi SA; Bashir MU; Yaqinuddin A
    Int J Surg; 2010; 8(3):194-8. PubMed ID: 20139036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
    Sadikovic B; Andrews J; Rodenhiser DI
    Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and therapeutic applications of epigenetics.
    Miyamoto K; Ushijima T
    Jpn J Clin Oncol; 2005 Jun; 35(6):293-301. PubMed ID: 15930038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic biomarkers for human cancer: the time is now.
    Mulero-Navarro S; Esteller M
    Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular diagnostic applications of DNA methylation technology.
    Cottrell SE
    Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating methylated DNA.
    Herman JG
    Ann N Y Acad Sci; 2004 Jun; 1022():33-9. PubMed ID: 15251936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated genes as new cancer biomarkers.
    Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
    Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island mapping by epigenome prediction.
    Bock C; Walter J; Paulsen M; Lengauer T
    PLoS Comput Biol; 2007 Jun; 3(6):e110. PubMed ID: 17559301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation and cancer diagnosis: new methods and applications.
    Dehan P; Kustermans G; Guenin S; Horion J; Boniver J; Delvenne P
    Expert Rev Mol Diagn; 2009 Oct; 9(7):651-7. PubMed ID: 19817550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment.
    Barton CA; Hacker NF; Clark SJ; O'Brien PM
    Gynecol Oncol; 2008 Apr; 109(1):129-39. PubMed ID: 18234305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of DNA methylation for cancer detection and molecular classification.
    Zhu J; Yao X
    J Biochem Mol Biol; 2007 Mar; 40(2):135-41. PubMed ID: 17394761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for sensitive and specific detection of DNA methylation biomarkers based on DNA restriction during PCR cycling.
    Kneip C; Schmidt B; Fleischhacker M; Seegebarth A; Lewin J; Flemming N; Seemann S; Schlegel T; Witt C; Liebenberg V; Dietrich D
    Biotechniques; 2009 Sep; 47(3):737-44. PubMed ID: 19852759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations as cancer diagnostic, prognostic, and predictive biomarkers.
    Deng D; Liu Z; Du Y
    Adv Genet; 2010; 71():125-76. PubMed ID: 20933128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprimo as a potential biomarker for early detection in gastric cancer.
    Bernal C; Aguayo F; Villarroel C; Vargas M; Díaz I; Ossandon FJ; Santibáñez E; Palma M; Aravena E; Barrientos C; Corvalan AH
    Clin Cancer Res; 2008 Oct; 14(19):6264-9. PubMed ID: 18829507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation profiling in cancer.
    Kondo Y; Issa JP
    Expert Rev Mol Med; 2010 Jul; 12():e23. PubMed ID: 20663272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation testing and marker validation using PCR: diagnostic applications.
    Egger G; Wielscher M; Pulverer W; Kriegner A; Weinhäusel A
    Expert Rev Mol Diagn; 2012 Jan; 12(1):75-92. PubMed ID: 22133121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.